Lipoprotein(a), lipids and proinflammatory cytokines in patients undergoing major abdominal surgery

British Journal of Surgery

Volumn 93, Issue 3, 2006, Pages 347-353

  Chimienti, G ^a   Aquilino, F ^a   Rotelli, M T ^a   Russo, F ^b   Lupo, L ^a   Pepe, G ^a,c  

^a UNIVERSITY OF BARI   (Italy)

^b NATIONAL INSTITUTE FOR DIGESTIVE DISEASES   (Italy)

^c Istituto di Biomembrane Bioenergetica   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 6; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ABDOMINAL SURGERY; ADULT; AGED; ARTICLE; CLINICAL OBSERVATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; KRINGLE DOMAIN; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SURGICAL STRESS; VARIABLE NUMBER OF TANDEM REPEAT;

ABDOMEN; ACUTE-PHASE REACTION; ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; APOLIPOPROTEINS; APOPROTEIN(A); ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INTERLEUKIN-6; LIPIDS; LIPOPROTEIN(A); MALE; MIDDLE AGED; NEOPLASMS; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33645059933     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.5273     Document Type: Article

References (29)

1. Utermann G. Lipoprotein(a). In The Metabolic & Molecular Bases of Inherited Disease (8th edn), Scriver CR, Beaudet AL, Sly WS, Valle D (eds), vol. 2. McGraw-Hill: New York, 2001; 2753-2787.
2. Danesh J, Collins R, Peto R. Lipoprotein(a) and coronary heart disease. Meta-analysis of prospective studies. Circulation 2000; 102: 1082-1085.
3. Maeda S, Abe A, Seishima M, Makino K, Noma A, Kawade M. Transient changes of serum lipoprotein(a) as an acute phase protein. Atherosclerosis 1989; 78: 145-150.
4. Min WK, Lee JO, Huh JW. Relation between lipoprotein(a) concentrations in patients with acute-phase response and risk analysis for coronary heart disease. Clin Chem 1997; 43: 1891-1895.
5. Lippi G, Braga V, Adami S, Guidi G. Modification of serum apolipoprotein A-I, apolipoprotein B and lipoprotein(a) levels after bisphosphonates-induced acute phase response. Clin Chim Acta 1998; 271: 79-87.
6. Musabak U, Baylan O, Cetin T, Yesilova Z, Sengul A, Saglam K et al. Lipid profile and anticardiolipin antibodies in Behcet's disease. Arch Med Res 2005; 36: 387-392.
7. Lee HY, Choi SJ, Ji JD, Seo HS, Song GG. Lipoprotein(a) and lipids in relation to inflammation in rheumatoid arthritis. Clin Rheumatol 2000; 19: 324-325.
8. Mooser V, Berger MM, Tappy L, Cayeux C, Marcovina SM, Darioli R et al. Major reduction in plasma Lp(a) levels during sepsis and burns. Arterioscler Thromb Vasc Biol 2000; 20: 1137-1142.
9. Kaklikkaya I, Ozdemir R, Orem A, Unal M, Sonmez B, Ozcan F. Course of serum lipoprotein(a) and acute phase protein levels in patients undergoing open heart surgery. J Cardiovasc Surg (Torino) 2002; 43: 811-815.
10. Milionis HJ, Mittari V, Exarchakos G, Kalaitzidis R, Skevas AT, Elisaf MS. Lipoprotein(a) and acute-phase response in patients with vestibular neuronitis. Eur J Clin Invest 2003; 33: 1045-1050.
11. Wade DP, Clarke JG, Lindahl GE, Liu AC, Zysow BR, Meer K et al. 5′ control regions of the apolipoprotein(a) gene and members of the related plasminogen gene family. Proc Natl Acad Sci USA 1993; 90: 1369-1373.
12. Frazer KA, Narla G, Zhang J Li, Rubin EM. The apolipoprotein(a) gene is regulated by sex hormones and acute-phase inducers in YAC transgenic mice. Nat Genet 1995; 9: 424-431.
13. Ramharack R, Barkalow D, Spahr M. Dominant negative effect of TGF-beta1 and TNF-alpha on basal and IL-6 induced Lipoprotein(a) and apolipoprotein(a) mRNA expression in primary monkey hepatocyte cultures. Arterioscler Thromb Vasc Biol 1998; 18: 984-990.
14. Terry CF, Loukaci V, Green FR. Cooperative influence of genetic polymorphism on interleukin-6 transcriptional regulation. J Biol Chem 2000; 275: 18 138-18 144.
15. Copeland GP, Jones D, Walters M. POSSUM: a scoring system for surgical audit. Br J Surg 1991; 78: 355-360.
16. Vickers MA, Green FR, Terry C, Mayosi BM, Julier C, Lathrop M et al. Genotype at a promoter polymorphism of the interleukin-6 gene is associated with baseline levels of plasma C-reactive protein. Cardiovascular Res 2002; 53: 1029-1034.
17. Horvath L, Csaszar A, Falus A, Dieplinger H, Horvath A, Puskas E et al. IL-6 and lipoprotein(a) [Lp(a)] concentrations are related only in patients with high apo(a) isoforms in monoclonal gammopathy. Cytokine 2002; 18: 340-343.
18. Jenner JL, Ordovas JM, Lamon-Fava S, Schaefer MM, Wilson PW, Castelli WP et al. Effect of age, sex, and menopausal status on plasma Lipoprotein(a) levels. The Framingham Offspring Study. Circulation 1993; 87: 1135-1141.
19. Güvener M, Ucar I, Ozkan M, Dogan OF, Serter FT, Pasaoglu I. Effect of cardiopulmonary bypass on plasma levels of lipoprotein(a) in hypercholesterolemic patients. Jpn Heart J 2001; 42: 563-574.
20. Rahel BM, Visseren FL, Suttorp MJ, Plokker TH, Kelder JC, de Jongh BM et al. Preprocedural serum levels of acute-phase reactants and prognosis after percutaneous coronary intervention. Cardiovasc Res 2003; 60: 136-140.
21. Tsimikas S, Lau HK, Han KR, Shortal B, Miller ER, Segev A et al. Percutaneous coronary intervention results in acute increases in oxidized phospholipids and lipoprotein(a): short-term and long-term immunologic responses to oxidized low-density lipoprotein. Circulation 2004; 109: 3164-3170.
22. Chimienti G, Lamanuzzi BL, Nardulli M, Colacicco AM, Capurso A, La Gioia R et al. Apo(a) variants and lipoprotein(a) in men with or without myocardial infarction. Exp Mol Pathol 2002; 73: 28-34.
23. Castell JV, Gómez-Lechón MJ, David M, Andus T, Geiger T, Trullenque R et al. Interleukin 6 is the major regulator of acute phase protein synthesis in adult human hepatocytes. FEBS Lett 1989; 242: 237-239.
24. Yano Y, Shimokawa K, Okada Y, Noma A. Immunolocalization of lipoprotein(a) in wounded tissues. J Histochem Cytochem 1997; 45: 559-568.
25. Akgun S, Ertel NH, Mosenthal A, Oser W. Postsurgical reduction of serum lipoproteins: interleukin-6 and the acute-phase response. J Lab Clin Med 1998; 131: 103-108.
26. Gierens H, Nauck M, Roth M, Schinker R, Schurmann C, Scharnagl H et al. Interleukin-6 stimulates LDL receptor gene expression via activation of sterol-responsive and Sp1 binding elements. Arterioscler Thromb Vasc Biol 2000; 20: 1777-1783.
27. Reblin T, Niemeier A, Meyer N, Willnow TE, Kronenberg F, Dieplinger H et al. Cellular uptake of lipoprotein(a) by mouse embryonic fibroblasts via the LDL receptor and the LDL receptor-related protein. J Lipid Res 1997; 38: 2103-2110.
28. Hofmann SL, Eaton DL, Brown MS, McConathy WJ, Goldstein JL, Hammer RE. Overexpression of human low density lipoprotein receptors leads to accelerated catabolism of Lp(a) lipoprotein in transgenic mice. J Clin Invest 1990; 85: 1542-1547.
29. 2-macroglobulin receptor. FEBS Lett 1993; 325: 271-275.